Literature DB >> 4638499

Availability of locally synthesized and systemic antibodies in the intestine.

E S Fubara, R Freter.   

Abstract

The present studies are concerned with the parameters which control the appearance of locally synthesized or serum-derived antibodies in the intestine. The data show that intestinal antibody may be found in rabbits as well as in conventional or germfree mice after active immunization with Vibrio cholerae. However, a large fraction of the intestinal antibody in rabbits and conventional mice originated from the serum as indicated by (i) analysis of correlation between serum and intestinal antibody titers, and (ii) the occurrence of intestinal antibody after parenteral administration of antiserum. In contrast, only locally synthesized 11S immunoglobulin A antibody was detected in the intestine of actively immunized germfree mice. No intestinal antibody was demonstrable in germfree mice after parenteral injection of V. cholerae antiserum. With respect to the appearance of serum antibody in the intestine, the response of conventionalized (ex-germfree) mice was intermediate between that of rabbits or conventional mice and germfree mice. The availability of serum-derived coproantibody in germfree and conventional mice was related to the rates of intestinal degradation of serum antibody. When enzymes were removed by prior washing of intestinal segments, serum antibodies entered the intestine of germfree or conventional mice at similar rates. Rates of entry of serum antibodies into the lumen were comparable at different levels of the small intestine. The presence of a normal enteric flora appeared to protect intestinal antibody from degradation by lowering the concentration or activity of intestinal enzymes. The results are discussed in relation to the question of whether antibacterial immunity to cholera involves local or systemic mechanisms.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4638499      PMCID: PMC443582          DOI: 10.1128/iai.6.6.965-981.1972

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  35 in total

1.  A method for determining the sedimentation behavior of enzymes: application to protein mixtures.

Authors:  R G MARTIN; B N AMES
Journal:  J Biol Chem       Date:  1961-05       Impact factor: 5.157

2.  The importance of antibody in the prevention of experimental cholera in rabbits.

Authors:  C R JENKIN; D ROWLEY
Journal:  Br J Exp Pathol       Date:  1960-02

3.  PASSIVE IMMUNITY IN EXPERIMENTAL CHOLERA.

Authors:  M V PANSE; H I JHALA; N K DUTTA
Journal:  J Infect Dis       Date:  1964-02       Impact factor: 5.226

4.  Bactericidal method for the measurement in normal serum of antibody to gramnegative bacteria.

Authors:  M LANDY; J G MICHAEL; J L WHITBY
Journal:  J Bacteriol       Date:  1962-03       Impact factor: 3.490

5.  Quantitative studies of the relationship between fecal and serum antibody.

Authors:  M E KOSHLAND; W BURROWS
Journal:  J Immunol       Date:  1950-07       Impact factor: 5.422

Review 6.  Secretory immunoglobulins.

Authors:  T B Tomasi; J Bienenstock
Journal:  Adv Immunol       Date:  1968       Impact factor: 3.543

7.  Demonstration of antibody in rabbit feces after active or passive parenteral immunization.

Authors:  J L McCleery; S C Kraft; R M Rothberg
Journal:  Digestion       Date:  1970       Impact factor: 3.216

8.  Immunological observations on experimental cholera.

Authors:  H K Ghosh
Journal:  J Med Microbiol       Date:  1970-08       Impact factor: 2.472

9.  Equine anti-hapten antibody. 3. The comparative properties of gamma G- and gammaA-antibodies.

Authors:  N R Klinman; J H Rockey; G Frauenberger; F Karush
Journal:  J Immunol       Date:  1966-04       Impact factor: 5.422

10.  Coproantibody and bacterial antagonism as protective factors in experimental enteric cholera.

Authors:  R FRETER
Journal:  J Exp Med       Date:  1956-09-01       Impact factor: 14.307

View more
  10 in total

1.  Antibacterial activity in colostrum and milk associated with protection of piglets against enteric disease caused by K88-positive Escherichia coli.

Authors:  J M Rutter; G W Jones; G T Brown; M R Burrows; P D Luther
Journal:  Infect Immun       Date:  1976-03       Impact factor: 3.441

2.  The agglutinating antibody response in the duodenum in infants with enteropathic E. coli gastroenteritis.

Authors:  A S McNeish; N Evans; H Gaze; K B Rogers
Journal:  Gut       Date:  1975-09       Impact factor: 23.059

3.  Immune response of athymic and euthymic germfree mice to Campylobacter spp.

Authors:  J W Yrios; E Balish
Journal:  Infect Immun       Date:  1986-11       Impact factor: 3.441

4.  Transfer of functional immunoglobulin G (IgG) antibody into the gastrointestinal tract accounts for IgG clearance in calves.

Authors:  T E Besser; T C McGuire; C C Gay; L C Pritchett
Journal:  J Virol       Date:  1988-07       Impact factor: 5.103

5.  The role of IgA immunoglobulins in the passive transfer of protection to Taenia taeniaeformis in the mouse.

Authors:  S Lloyd; E J Soulsby
Journal:  Immunology       Date:  1978-05       Impact factor: 7.397

6.  Specificity of secretory antibodies to bacterial immunogens.

Authors:  J L Ebersole; J A Molinari
Journal:  Infect Immun       Date:  1976-01       Impact factor: 3.441

7.  immunoglobulin and histamine-sensitivity response of mice to live Bordetella pertussis.

Authors:  B D Geller; M Pittman
Journal:  Infect Immun       Date:  1973-07       Impact factor: 3.441

8.  Gastrointestinal antibody responses in axenic mice to topically administered Escherichia coli.

Authors:  J L Ebersole; J A Molinari
Journal:  Infect Immun       Date:  1977-06       Impact factor: 3.441

9.  The transfer of serum IgG1 antibody into the gastrointestinal tract in newborn calves.

Authors:  T E Besser; T C McGuire; C C Gay
Journal:  Vet Immunol Immunopathol       Date:  1987-12       Impact factor: 2.046

Review 10.  Protective Microbiota: From Localized to Long-Reaching Co-Immunity.

Authors:  Lynn Chiu; Thomas Bazin; Marie-Elise Truchetet; Thierry Schaeverbeke; Laurence Delhaes; Thomas Pradeu
Journal:  Front Immunol       Date:  2017-12-07       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.